Innate immune response in CF airway epithelia: Hyperinflammatory?

American Journal of Physiology - Cell Physiology

Volumn 291, Issue 2, 2006, Pages

  Machen, Terry E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acidic airway surface liquid; Calcium; NF B; Oxidative stress; Pseudomonas aeruginosa; Toll like receptor

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ANNEXIN; BRADYKININ; CALCIUM ION; CARBONIC ACID; CHLORIDE ION; COLONY STIMULATING FACTOR; CYCLIC AMP; CYTOKINE; FLAGELLIN; GLUTATHIONE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; PDZ PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; REACTIVE OXYGEN METABOLITE; SODIUM PROTON EXCHANGE PROTEIN; TOLL LIKE RECEPTOR 5; TRANSCRIPTION FACTOR AP 1; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ANION TRANSPORT; APICAL MEMBRANE; BACTERIUM ADHERENCE; BASOLATERAL MEMBRANE; BRONCHUS MUCUS; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL PH; CYSTIC FIBROSIS; CYTOKINE RELEASE; EPITHELIUM CELL; GOLGI COMPLEX; HUMAN; INFLAMMATION; INNATE IMMUNITY; LUNG INJURY; MEMBRANE POTENTIAL; MUCOCILIARY CLEARANCE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; INFLAMMATION; MODELS, IMMUNOLOGICAL; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION;

PSEUDOMONAS AERUGINOSA;

EID: 33746583563     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00605.2005     Document Type: Review

References (199)

1. Adamo R, Sokol S, Soong G, Gomez MI, and Prince A. Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5. Am J Respir Cell Mol Biol 30: 627-634, 2004.
2. Akira S and Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4: 499-511, 2004.
3. Aldallal N, McNaughton EE, Manzel LJ, Richards AM, Zabner J, Ferkol TW, and Look DC. Inflammatory response in airway epithelial cells isolated from patients with cystic fibrosis. Am J Respir Crit Care Med 166: 1248-1256, 2002.
4. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, and Schwartz DA. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191, 2000.
5. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutierrez JP, Hull J, Olinsky A, Phelan EM, Robertson CF, and Phelan PD. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 156: 1197-1204, 1997.
6. Babnigg G, Heller B, and Villereal ML. Cell-to-cell variation in store-operated calcium entry in HEK-293 cells and its impact on the interpretation of data from stable clones expressing exogenous calcium channels. Cell Calcium 27: 61-73, 2000.
7. Baeuerle PA and Baltimore D. NF-κB: ten years after. Cell 87: 13-20, 1995.
8. Ballard ST and Inglis SK. Liquid secretion properties of airway submucosal glands. J Physiol 556: 1-10, 2004.
9. Barasch J, Kiss B, Prince A, Saiman L, Gruenert D, and al-Awqati Q. Defective acidification of intracellular organelles in cystic fibrosis. Nature 352: 70-73, 1991.
10. Becker MN, Sauer MS, Muhlebach MS, Hirsh AJ, Wu Q, Verghese MW, and Randell SH. Cytokine secretion by cystic fibrosis airway epithelial cells. Am J Respir Crit Care Med 169: 645-653, 2004.
11. Bennett WD, Olivier KN, Zeman KL, Hohneker KW, Boucher RC, and Knowles MR. Effect of uridine 5′-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Am J Respir Crit Care Med 153: 1796-1801, 1996.
12. Bensalem N, Ventura AP, Vallee B, Lipecka J, Tondelier D, Davezac N, Santos AD, Perretti M, Fajac A, Sermet-Gaudelus I, Renouil M, Lesure JF, Halgand F, Laprevote O, and Edelman A. Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients. Mol Cell Proteomics 4: 1591-1601, 2005.
13. Bishop C, Hudson VM, Hilton SC, and Wilde C. A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis. Chest 127: 308-317, 2005.
14. Blaug S, Hybiske K, Cohn J, Firestone GL, Machen TE, and Miller SS. ENaC- and CFTR-dependent ion and fluid transport in mammary epithelia. Am J Physiol Cell Physiol 281: C633-C642, 2001.
15. Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, and Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 13: 257-261, 1995.
16. Bonfield TL, Konstan MW, and Berger M. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 104: 72-78, 1999.
17. Boucher RC, Stutts MJ, Knowles MR, Cantley L, and Gatzy JT. Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J Clin Invest 78: 1245-1252, 1986.
18. Bresser P, Out TA, van Alphen L, Jansen HM, and Lutter R. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with non-infected patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162: 947-952, 2000.
19. Brockhausen I, Vavasseur F, and Yang X. Biosynthesis of mucin type O-glycans: lack of correlation between glycosyltransferase and sulfotransferase activities and CFTR expression. Glycoconj J 18: 685-697, 2001.
20. Bruzzese E, Riaia V, Baudiello G, Polito G, Buccigrossi V, Formicola V, and Guarino A. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 20: 813-819, 2004.
21. Bryan R, Kube D, Perez A, Davis PB, and Prince A. Overproduction of the CFTR R-domain leads to increased levels of asialoGM1 and increased P. aeruginosa binding by epithelial cells. Am J Respir Cell Mol Biol 19: 269-277, 1998.
22. Carrabino S, Carpani D, Livraghi A, Di Cicco M, Costantini D, Copreni E, Colombo C, and Conese M. Dysregulated interleukin-8 secretion and NF-κB activity in human cystic fibrosis nasal epithelial cells. J Cyst Fibros 5: 113-119, 2006.
23. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, and Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95: 11715-11720, 1998.
24. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, and Schumacker PT. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1 during hypoxia: a mechanism of O2 sensing. J Biol Chem 275: 25130-25138, 2000.
25. Chandy G, Grabe M, Moore HP, and Machen TE. Proton leak and CFTR in regulation of Golgi pH in respiratory epithelial cells. Am J Physiol Cell Physiol 281: C908-C921, 2001.
26. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, and Smith AE. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63: 827-834, 1990.
27. Clapham DE. TRP channels as cellular sensors. Nature 426: 517-524, 2003.
28. Coakley RD, Grubb BR, Paradiso AM, Gatzy JT, Johnson LG, Kreda SM, O'Neal WK, and Boucher RC. Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc Natl Acad Sci USA 100: 16083-16088, 2003.
29. Cobb LM, Mychaleckyj JC, Wozniak DJ, and Lopez-Boado YS. Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease. J Immunol 173: 5659-5670, 2004.
30. Cole AM, Dewan P, and Ganz T. Innate antimicrobial activity of nasal secretions. Infect Immun 67: 3267-3275, 1999.
31. Dakin CJ, Numa AH, Wang H, Morton JR, Vertzyas CC, and Henry RL. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 165: 904-10, 2002.
32. Darling KE, Dewar A, and Evans TJ. Role of the cystic fibrosis transmembrane conductance regulator in internalization of Pseudomonas aeruginosa by polarized respiratory epithelial cells. Cell Microbiol 6: 521-537, 2004.
33. De Bentzmann S, Roger P, Dupuit F, Bajolet-Laudinat O, Fuchey C, Plotkowski MC, and Puchelle E. Asialo GM1 is a receptor for Pseudomonas aeruginosa adherence to regenerating respiratory epithelial cells. Infect Immun 64: 1582-1588, 1996.
34. Denning GM, Wollenweber LA, Railsback MA, Cox CD, Stoll LL, and Britigan BE. Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect Immun 66: 5777-5784, 1998.
35. DiMango E, Zar HJ, Bryan R, and Prince A. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 96: 2204-2210, 1995.
36. DiMango E, Ratner AJ, Bryan R, Tabibi S, and Prince A. Activation of NF-κB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 101: 2598-2605, 1998.
37. 2+response amplitude and duration. Nature 386: 855-858, 1997.
38. Dosanjh A, Lencer W, Brown D, Ausiello DA, and Stow JL. Heterologous expression of ΔF508 CFTR results in decreased sialylation of membrane glycoconjugates. Am J Physiol Cell Physiol 266: C360-C366, 1994.
39. Dunn KW, Park J, Semrad CE, Gelman DL, Shevell T, and McGraw TE. Regulation of endocytic trafficking and acidification are independent of the cystic fibrosis transmembrane regulator. J Biol Chem 269: 5336-5345, 1994.
40. 2+ signaling, and gene expression in T lymphocytes. J Exp Med 188: 1593-1602, 1998.
41. Eidelman O, Srivastava M, Zhang J, Leighton X, Murtie J, Jozwik C, Jacobson K, Weinstein DL, Metcalf EL, and Pollard HB. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-αR/NF-κB pathway. Mol Med 7: 523-534, 2001.
42. Engelhardt JF, Zepeda M, Cohn JA, Yankaskas JR, and Wilson JM. Expression of the cystic fibrosis gene in adult human lung. J Clin Invest 93: 737-749, 1994.
43. Estell K, Braunstein G, Tucker T, Varga K, Collawn JF, and Schwiebert LM. Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif. Mol Cell Biol 23: 594-606, 2003.
44. Fischer H, Illek B, Negulescu PA, Clauss W, and Machen TE. Carbachol-activated Ca entry into HT-29 cells is regulated by both membrane potential and cell volume. Proc Natl Acad Sci USA 89: 1438-1442, 1992.
45. Fischer H, Widdicombe JH, and Illek B. Acid secretion and proton conductance in human airway epithelium. Am J Physiol Cell Physiol 282: C736-C743, 2002.
46. Fleiszig SM, Evans DJ, Do N, Vallas V, Shin S, and Mostov KE. Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity. Infect Immun 65: 2861-2867, 1997.
47. Gao L, Kim KJ, Yankaskas JB, and Forman HJ. Abnormal glutathione transport in cystic fibrosis airway epithelia. Am J Physiol Lung Cell Mol Physiol 277: L113-L118, 1999.
48. Gelman MS, Kannegaard ES, and Kopito RR. A principal role for the proteasome in endoplasmic reticulum-associated degradation of misfolded intracellular cystic fibrosis transmembrane conductance regulator. J Biol Chem 277: 11709-11714, 2002.
49. Gibson GA, Hill WG, and Weisz OA. Evidence against the acidification hypothesis in cystic fibrosis. Am J Physiol Cell Physiol 279: C1088-C1099, 2000.
50. Gomez MI, Lee A, Reddy B, Muir A, Soong G, Pitt A, Cheung A, and Prince A. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med 10: 842-848, 2004.
51. Grassme H, Jendrossek V, Riehle A, von Kurthy G, Berger J, Schwarz H, Weller M, Kolesnick R, and Gulbins E. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 9: 322-330, 2003.
52. Greene CM, Carroll TP, Smith SG, Taggart CC, Devaney J, Griffin S, O'Neill SJ, and McElvaney NG. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J Immunol 174: 1638-1646, 2005.
53. + exchanger regulatory factor isoform 1 overexpression modulates cystic fibrosis transmembrane conductance regulator (CFTR) expression and activity in human airway 16HBE14o- cells and rescues ΔF508 CFTR functional expression in cystic fibrosis cells. J Biol Chem 280: 40925-40933, 2005.
54. Hallows KR, Fitch AC, Richardson CA, Reynolds PR, Clancy JP, Dagher PC, Witters LA, Kolls JK, and Pilewski JM. Up-regulation of AMP-activated kinase by dysfunctional cystic fibrosis transmembrane conductance regulator in cystic fibrosis airway epithelial cells mitigates excessive inflammation. J Biol Chem 281: 4231-4241, 2006.
55. Hallows KR, Kobinger GP, Wilson JM, Witters LA, and Foskett JK. Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. Am J Physiol Cell Physiol 284: C1297-C1308, 2003.
56. Hallows KR, McCane JE, Kemp BE, Witters LA, and Foskett JK. Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells. J Biol Chem 278: 998-1004, 2003.
57. Hallows KR, Raghuram V, Kemp BE, Witters LA, and Foskett JK. Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. J Clin Invest 105: 1711-1721, 2000.
58. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, and Aderem A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103, 2001.
59. Hertz CJ, Wu Q, Porter EM, Zhang YJ, Weismuller KH, Godowski PJ, Ganz T, Randell SH, and Modlin RL. Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human β-defensin-2. J Immunol 171: 6820-6826, 2003.
60. Hirsila M, Koivunen P, Gunzler V, Kivirikko KI, and Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278: 30772-30780, 2003.
61. Homma T, Kato A, Hashimoto N, Batchelor J, Yoshikawa M, Imai S, Wakiguchi H, Saito H, and Matsumoto K. Corticosteroid and cytokines synergistically enhance toll-like receptor 2 expression in respiratory epithelial cells. Am J Respir Cell Mol Biol 31: 463-469, 2004.
62. Hudson VM. New insights into the pathogenesis of cystic fibrosis: pivotal role of glutathione system dysfunction and implications for therapy. Treat Respir Med 3: 353-363, 2004.
63. Hybiske K, Ichikawa JK, Huang V, Lory SJ, and Machen TE. Cystic fibrosis airway epithelial cell polarity and bacterial flagellin determine host response to Pseudomonas aeruginosa. Cell Microbiol 6: 49-63, 2004.
64. - conductance through CFTR in human airway epithelia. Am J Physiol Lung Cell Mol Physiol 272: L752-L761, 1997.
65. Imberty A, Wimmerova M, Mitchell EP, and Gilboa-Garber N. Structures of the lectins from Pseudomonas aeruginosa: insight into the molecular basis for host glycan recognition. Microbes Infect 6: 221-228, 2004.
66. Imundo L, Barasch J, Prince A, and Al-Awqati Q. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc Natl Acad Sci USA 92: 3019-3023, 1995.
67. Inglis SK, Wilson SM, and Olver RE. Secretion of acid and base quivalents by intact distal airways. Am J Physiol Lung Cell Mol Physiol 284: L855-L862, 2003.
68. 2+ concentration in airway epithelial cells by Pseudomonas aeruginosa. Infect Immun 70: 6399-6408, 2002.
69. +] and pH but elevated viscosity. Proc Natl Acad Sci USA 98: 8119-8123, 2001.
70. Jayaraman S, Song Y, and Verkman AS. Airway surface liquid pH in well-differentiated airway epithelial cell cultures and mouse trachea. Am J Physiol Cell Physiol 281: C1504-C1511, 2001.
71. Jia HP, Kline JN, Penisten A, Apicella MA, Gioannini TL, Weiss J, and McCray PB Jr. Endotoxin responsiveness of human airway epithelia is limited by low expression of MD-2. Am J Physiol Lung Cell Mol Physiol 287: L428-L437, 2004.
72. Jiang X, Hill WG, Pilewski JM, and Weisz OA. Glycosylation differences between a cystic fibrosis and rescued airway cell line are not CFTR dependent. Am J Physiol Lung Cell Mol Physiol 273: L913-L920, 1997.
73. Joo NS, Irokawa T, Robbins RC, and Wine JJ. Hyposecretion, not hyperabsorption, is the basic defect of cystic fibrosis airway glands. J Biol Chem 281: 7392-7398, 2006.
74. Joseph T, Look D, and Ferkol T. NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 288: L471-L479, 2005.
75. Kabe Y, Ando K, Hirao S, Yoshida M, and Handa H. Redox regulation of NF-κB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7: 395-403, 2005.
76. Karp CL, Flick LM, Park KW, Softic S, Greer TM, Keledjian R, Yang R, Uddin J, Guggino WB, Atabani SF, Belkaid Y, Xu Y, Whitsett JA, Accurso FJ, Wills-Karp M, and Petasis NA. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immun 5: 388-392, 2004.
77. Kaur S, Norkina O, Ziemer D, Samuelson LC, and De Lisle RC. Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas. Am J Physiol Gastrointest Liver Physiol 287: G480-G490, 2004.
78. Kelley TJ and Drumm ML. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 102: 1200-1207, 1998.
79. Kelley TJ and Elmer HL. In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium. J Clin Invest 106: 403-410, 2000.
80. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, and Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151: 1075-1082, 1995.
81. Kim SK, Woodcroft KJ, Oh SJ, Abdelmegeed MA, and Novak RF. Role of mechanical and redox stress in activation of mitogen-activated protein kinases in primary cultured rat hepatocytes. Biochem Pharmacol 70: 1785-1795, 2005.
82. Knowles MR and Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109: 571-577, 2002.
83. Koch A, Giembycz M, Ito K, Lim S, Jazrawi E, Barnes PJ, Adcock I, Erdmann E, and Chung KF. Mitogen-activated protein kinase modulation of nuclear factor-κB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages. Am J Respir Cell Mol Biol 30: 342-349, 2004.
84. Konstan MW and Davis PB. Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis. Adv Drug Delivery Res 54: 1409-1423, 2002.
85. Kopito RR. Biosynthesis and degradation of CFTR. Physiol Rev 79: S167-S173, 1999.
86. Kowalski MP and Pier GB. Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. J Immunol 172: 418-425, 2004.
87. Kreda SM, Mall M, Mengos A, Rochelle L, Yankaskas J, Riordan JR, and Boucher RC. Characterization of wild-type and ΔF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell 16: 2154-2167, 2005.
88. Kreiselmeier NE, Kraynack NC, Corey DA, and Kelley TJ. Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells. Am J Physiol Lung Cell Mol Physiol 285: L1286-L1295, 2003.
89. Krouse ME, Talbott JF, Lee MM, Joo NS, and Wine JJ. Acid and base secretion in the Calu-3 model of human serous cells. Am J Physiol Lung Cell Mol Physiol 287: L1274-L1283, 2004.
90. Kube D, Sontic U, Fletcher D, and Davis PB. Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. Am J Physiol Lung Cell Mol Physiol 280: L493-L502, 2001.
91. Kyle H, Ward JP, and Widdicombe JG. Control of pH of airway surface liquid of the ferret trachea in vitro. J Appl Physiol 68: 135-140, 1990.
92. Lamblin G, Degroote S, Perini JM, Delmotte P, Scharfman A, Davril M, Lo-Guidice JM, Houdret N, Dumur V, Klein A, and Rousse P. Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis. Glycoconj J 18: 661-684, 2001.
93. Lando D, Peet DJ, Whelan DA, Gorman JJ, and Whitelaw ML. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295: 858-861, 2002.
94. Lee A, Chow D, Tseng W, Haus B, Evans D, Fleiszig S, Chandy G, and Machen TE. Airway epithelial tight junctions and binding and cytotoxicity of Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 277: L204-L217, 1999.
95. Lee MC, Penland CM, Widdicombe JH, and Wine JJ. Evidence that Calu-3 human airway cells secrete bicarbonate. Am J Physiol Lung Cell Mol Physiol 274: L450-L453, 1998.
96. Leir SH, Parry S, Palmai-Pallag T, Evans J, Morris HR, Dell A, and Harris A. Mucin glycosylation and sulphation in airway epithelial cells is not influenced by cystic fibrosis transmembrane conductance regulator expression. Am J Respir Cell Mol Biol 32: 453-461, 2005.
97. + exchanger regulatory factor and the cystic fibrosis transmembrane conductance regulator. J Biol Chem 280: 37634-37643, 2005.
98. + channel remodeling in rat ventricle. J Mol Cell Cardiol 40: 339-349, 2006.
99. Li Y, Wang W, Parker W, and Clancy JP. Adenosine regulation of CFTR through prostenoids in airway epithelia. Am J Respir Cell Mol Biol 34: 600-608, 2006.
100. Lindstrom M, Camner P, Falk R, Hjelte L, Philipson K, and Svartengren M. Long-term clearance from small airways in patients with cystic fibrosis. Eur Respir J 25: 317-323, 2005.
101. Linsdell P and Hanrahan JW. Glutathione permeability of CFTR. Am J Physiol Cell Physiol 275: C323-C326, 1998.
102. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, and Verkman AS. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 110: 1651-1658, 2002.
103. 2+ synergism in flagellin-activated innate immune responses of airway epithelia. Ped Pulmon. In press.
104. +-ATPase-transfected HEK-293 cells: implications for pH regulation in the secretory pathway. Am J Physiol Cell Physiol 285: C205-C214, 2003.
105. Matos TJ, Duarte CB, Goncalo M, and Lopes MC. Role of oxidative stress in ERK and p38 MAPK activation induced by the chemical sensitizer DNFB in a fetal skin dendritic cell line. Immunol Cell Biol 83: 607-614, 2005.
106. McNamara N and Basbaum C. Mechanism by which bacterial flagellin stimulates host mucin production. Adv Exp Med Biol 506: 269-273, 2002.
107. McNamara N, Khong A, McKemy D, Caterina M, Boyer J, Julius D, and Basbaum C. ATP transduces signals from ASGM1, a glycolipid that functions as a bacterial receptor. Proc Natl Acad Sci USA 98: 9086-9091, 2001.
108. McNamara N, Gallup M, Sucher A, Maltseva I, McKemy D, and Basbaum C. ASIALOGM1 and TLR5 cooperate in flagellin-induced nucleotide signaling to activate ERK1/2. Am J Respir Cell Mol Biol. In Press.
109. McShane D, Davies JC, Wodehouse T, Bush A, Geddes D, and Alton EW. Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect. Eur Respir J 24: 95-100, 2004.
110. Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJ, and Verkman AS. Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J Gen Physiol 124: 125-137, 2004.
111. Muhlebach MS, Stewart PW, Leigh MW, and Noah TL. Quantification of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 160: 186-191, 1999.
112. Muir A, Soong G, Sokol S, Reddy B, Gomez MI, Van Heeckeren A, and Prince A. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 30: 777-783, 2004.
113. Negulescu PA and Machen TE. Cellular ion activities and membrane transport in parietal cells measured with fluorescent probes. Methods Enzymol 192: 38-81, 1990.
114. Negulescu PA, Shastri N, and Cahalan MD. Intracellular calcium dependence of gene expression in single T lymphocytes. Proc Natl Acad Sci USA 91: 2873-2877, 1994.
115. Noah TL, Black HR, Cheng PW, Wood RE, and Leigh MW. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 175: 638-647, 1997.
116. Norkina O, Burnett TG, and De Lisle RC. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immun 72: 6040-6049, 2004.
117. Norkina O, Kaur S, Ziemer D, and De Lisle RC. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 286: G1032-G1041, 2004.
118. 2+ and reactive oxygen intermediates as messengers. FEBS Lett 392: 129-136, 1996.
119. Pahl HL, Sester M, Burgert HG, and Baeurle PA. Activation of transcription factor NF-B by the adenovirus E3/19K protein requires its ER retention. J Cell Biol 132: 511-522, 1996.
120. - transport in human normal and cystic fibrosis nasal epithelia. J Physiol 548: 203-218, 2003.
121. Paradiso AM, Ribeiro CM, and Boucher RC. Polarized signaling via purinoceptors in normal and cystic fibrosis airway epithelia. J Gen Physiol 117: 53-67, 2001.
122. Patil C and Walter P. Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr Opin Cell Biol 13: 349-355, 2001.
123. + ATPase in lower airway epithelium from cystic fibrosis and non-cystic-fibrosis lung. Biochem Biophys Res Commun 232: 464-468, 1997.
124. Perez A and Davis PB. Gene profile changes after Pseudomonas aeruginosa exposure in immortalized airway epithelial cells. J Struct Funct Genomics 5: 179-194, 2004.
125. Perez-Vilar J and Boucher RC. Reevaluating gel-forming mucins' roles in cystic fibrosis lung disease. Free Radic Biol Med 37: 1564-1577, 2004.
126. Pier GB. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. Proc Natl Acad Sci USA 97: 8822-8828, 2000.
127. Pier GB. CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection. Curr Opin Microbiol 5: 81-86, 2002.
128. Pier GB, Grout M, and Zaidi TS. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci USA 94: 12088-12093, 1997.
129. Pier GB, Grout M, Zaidi TS, Olsen JC, Johnson LG, Yankaskas JR, and Goldberg JB. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271: 64-67, 1996.
130. Pizurki L, Morris MA, Chanson M, Solomon M, Pavirani A, Bouchardy I, and Suter S. Cystic fibrosis transmembrane conductance regulator does not affect neutrophil migration across cystic fibrosis airway epithelial monolayers. Am J Pathol 156: 1407-1416, 2000.
131. Poschet JF, Boucher JC, Tatterson L, Skidmore J, Van Dyke RW, and Deretic V. Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung. Proc Natl Acad Sci USA 98: 13972-13977, 2001.
132. Poulsen JH, Fischer H, Illek B, and Machen TE. Bicarbonate conductance and pH regulatory capability of CFTR. Proc Natl Acad Sci USA 91: 5340-5344, 1994.
133. Raia V, Maiuri L, de Ritis G, de Vizia B, Vacca L, Conte R, Auricchio S, and Londei M. Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. Pediatr Res 47: 344-350, 2000.
134. Ramos HC, Rumbo M, and Sirard JC. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol 12: 509-517, 2004.
135. Ramphal R, McNiece MT, and Pollack FD. Adherence of Pseudomonas aeruginosa to injured cornea. A step in pathogenesis of corneal infections. Ann Ophthalmol 100: 1956-1958, 1981.
136. Ran H, Hassett DJ, and Lau GW. Human targets of Pseudomonas aeruginosa pyocyanin. Proc Natl Acad Sci USA 100: 14315-14320, 2003.
137. 2+-dependent mitogen-activated protein kinase signaling pathways in airway epithelial cells. J Biol Chem 276: 19267-19275, 2001.
138. Ratner AJ, Lysenko ES, Paul MN, and Weiser JN. Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc Natl Acad Sci USA 102: 3429-3434, 2005.
139. Reddy MM and Quinton PM. Altered electrical potential profile of human reabsorptive sweat duct cells in cystic fibrosis. Am J Physiol Cell Physiol 257: C722-C726, 1989.
140. Reid CJ, Burdick MD, Hollingsworth MA, and Harris A. CFTR expression does not influence glycosylation of an epitope-tagged MUC1 mucin in colon carcinoma cell lines. Glycobiology 9: 389-398, 1999.
141. Reiniger N, Ichikawa JK, and Pier GB. Influence of cystic fibrosis transmembrane conductance regulator on gene expression in response to Pseudomonas aeruginosa infection of human bronchial epithelial cells. Infect Immun 73: 6822-6830, 2005.
142. 2+ regulation in cystic fibrosis nasal epithelial cells. Proc Natl Acad Sci USA 89: 2955-2959, 1992.
143. Rhim AD, Stoykova L, Glick MC, and Scanlin TF. Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell. Glycoconj J 18: 649-659, 2001.
144. 2+i signals in human cystic fibrosis airway epithelia. J Biol Chem 280: 10202-10209, 2005.
145. 2+i-dependent hyperinflammatory response in human cystic fibrosis airway epithelia. J Biol Chem 280: 17798-17806, 2005.
146. Ribeiro CM, Paradiso AM, Livraghi A, and Boucher RC. The mitochondrial barriers segregate agonist-induced calcium-dependent functions in human airway epithelia. J Gen Physiol 122: 377-387, 2003.
147. Rodgers HC, Pang L, Holland E, Corbett L, Range S, and Knox AJ. Bradykinin increases IL-8 generation in airway epithelial cells via COX-2-derived prostanoids. Am J Physiol Lung Cell Mol Physiol 283: L612-L618, 2002.
148. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Kehagia V, Jones GR, and Bruce KD. Bacterial activity in cystic fibrosis lung infections. Respir Res 6: 49, 2005.
149. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, and Bruce KD. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 42: 5176-5178, 2004.
150. Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, and Ramsey BW. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 32: 356-366, 2001.
151. Roum JH, Buhl R, McElvaney NG, Borok Z, and Crystal RG. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol 75: 2419-2424, 1993.
152. Sadikot RT, Blackwell TS, Christman JW, and Prince AS. Pathogenhost interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 171: 1209-1223, 2005.
153. Saiman L and Prince AP. Aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest 92: 1875-1880, 1993.
154. Sand P, Svenberg T, and Rydqvist B. Carbachol induces oscillations in membrane potential and intracellular calcium in a colonic tumor cell line, HT-29. Am J Physiol Cell Physiol 273: C1186-C1193, 1997.
155. Scanlin TF and Glick MC. Terminal glycosylation in cystic fibrosis. Biochim Biophys Acta 1455: 241-253, 1999.
156. Schapiro FB and Grinstein S. Determinants of the pH of the Golgi complex. J Biol Chem 275: 21025-21032, 2000.
157. Schroedl C, McClintock DS, Budinger GR, and Chandel NS. Hypoxic but not anoxic stabilization of HIF-1 requires mitochondrial reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 283: L922-L931, 2002.
158. Schulz BL, Sloane AJ, Robinson LJ, Sebastian LT, Glanville AR, Song Y, Verkman AS, Harry JL, Packer NH, and Karlsson NG. Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions. Biochem J 387: 911-919, 2005.
159. Schwiebert LM, Estell K, and Propst SM. Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression. Am J Physiol Cell Physiol 276: C700-C710, 1999.
160. Seksek O, Biwersi J, and Verkman AS. Evidence against defective trans-Golgi acidification in cystic fibrosis. J Biol Chem 271: 15542-15548, 1996.
161. Shori DK, Kariyawasam HH, Knight RA, Hodson ME, Genter T, Hansen J, Koch C, and Kalogeridis A. Sulphation of the salivary mucin MG1 (MUC-5B) is not correlated to the degree of its sialylation and is unaffected by cystic fibrosis. Pflügers Arch 443: S50-S4, 2001.
162. Smith RS, Fedyk ER, Springer TA, Mukaida N, Iglewski BH, and Phipps RP. IL-8 production in human lung fibroblasts and epithelial cells activated by the Pseudomonas autoinducer N-3-oxododecanoyl homoserine lactone is transcriptionally regulated by NF-κB and activator protein-2. J Immunol 167: 366-374, 2001.
163. Smith JJ and Welsh MJ. cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia. J Clin Invest 89: 1148-1153, 1992.
164. Smyth RL, Croft NM, O'Hea U, Marshall TG, and Ferguson A. Intestinal inflammation in cystic fibrosis. Arch Dis Child 82: 394-399, 2000.
165. Song Y, Thiagarajah J, and Verkman AS. Sodium and chloride concentrations, pH, and depth of airway surface liquid in distal airways. J Gen Physiol 122: 511-519, 2003.
166. Srivastava M, Eidelman O, Zhang J, Paweletz C, Caohuy H, Yang Q, Jacobson KA, Heldman E, Huang W, Jozwik C, Pollard BS, and Pollard HB. Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells. Proc Natl Acad Sci USA 101: 7693-7698, 2004.
167. Srivastava M, Eidelman O, and Pollard HB. Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis. Mol Med 5: 753-767, 1999.
168. Steagall WK, Elmer HL, Brady KG, and Kelley TJ. Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression. Am J Respir Cell Mol Biol 22: 45-50, 2000.
169. Stutts MJ, Knowles MR, Gatzy JT, and Boucher RC. Oxygen consumption and ouabain binding sites in cystic fibrosis nasal epithelium. Pediatr Res 20: 1316-1320, 1986.
170. Sun F, Hug MJ, Lewarchik CM, Yun CH, Bradbury NA, and Frizzell RA. E3KARP mediates the association of ezrin and protein kinase A with the cystic fibrosis transmembrane conductance regulator in airway cells. J Biol Chem 275: 29539-29546, 2000.
171. Tabary O, Escotte S, Couetil JP, Hubert D, Dusser D, Puchelle E, and Jacquot J. High susceptibility for cystic fibrosis human airway gland cells to produce IL-8 through the IγB kinase-α pathway in response to extracellular NaCl content. J Immunol 164: 3377-3384, 2000.
172. Taddei A, Folli C, Zegarra-Moran O, Fanen P, Verkman AS, and Galietta LJ. Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker. FEBS Lett 558: 52-56, 2004.
173. Tamada T, Hug MJ, Frizzell RA, and Bridges RJ. Microelectrode and impedance analysis of anion secretion in Calu-3 cells. JOP 2: 219-228, 2001.
174. Tchilibon S, Zhang J, Yang Q, Eidelman O, Kim H, Caohuy H, Jacobson KA, Pollard BS, and Pollard HB. Amphiphilic pyridinium salts block TNFα/NFκB signaling and constitutive hypersecretion of interleukin-8 (IL-8) from cystic fibrosis lung epithelial cells. Biochem Pharmacol 70: 381-393, 2005.
175. Thomsson KA, Hinojosa-Kurtzberg M, Axelsson KA, Domino SE, Lowe JB, Gendler SJ, and Hansson GC. Intestinal mucins from cystic fibrosis mice show increased fucosylation due to an induced Fucα1-2 glycosyltransferase. Biochem J 367: 609-616, 2002.
176. Tirouvanziam R, de Bentzmann S, Hubeau C, Hinnrasky J, Jacquot J, Peault B, and Puchelle E. Inflammation and infection in naive human cystic fibrosis airway grafts. Am J Respir Cell Mol Biol 23: 121-127, 2000.
177. Trout L, King M, Feng W, Inglis SK, and Ballard ST. Inhibition of airway liquid secretion and its effect on the physical properties of airway mucus. Am J Physiol Lung Cell Mol Physiol 274: L258-L263, 1998.
178. Travassos LH, Carneiro LA, Girardin SE, Boneca IG, Lemos R, Bozza MT, Domingues RC, Coyle AJ, Bertin J, Philpott DJ, and Plotkowski MC. Nod1 participates in the innate immune response to Pseudomonas aeruginosa. J Biol Chem 280: 36714-36718, 2005.
179. Tseng J, Do J, Widdicombe JH, and Machen TE. Innate immune responses to P. aeruginosa flagellin, TNF-α and IL-1β. Am J Physiol Cell Physiol 290: C678-C690, 2006.
180. Ulrich M, Herbert S, Berger J, Bellon G, Louis D, Munker G, and Doring G. Localization of Staphylococcus aureus in infected airways of patients with cystic fibrosis and in a cell culture model of S. aureus adherence. Am J Respir Cell Mol Biol 19: 83-91, 1998.
181. Urban TA, Griffith A, Torok AM, Smolkin ME, Burns JL, and Goldberg JB. Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation. Infect Immun 72: 5126-5134, 2004.
182. Uyekubo SN, Fischer H, Maminishkis A, Illek B, Miller SS, and Widdicombe JH. cAMP-dependent absorption of chloride across airway epithelium. Am J Physiol Lung Cell Mol Physiol 275: L1219-L1227, 1998.
183. Van Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, and Ferkol T. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 100: 2810-2815, 1997.
184. Varga K, Jurkuvenaite A, Wakefield J, Hong JS, Guimbellot JS, Venglarik CJ, Niraj A, Mazur M, Sorscher EJ, Collawn JF, and Bebok Z. Efficient intracellular processing of the endogenous cystic fibrosis transmembrane conductance regulator in epithelial cell lines. J Biol Chem 279: 22578-22584, 2004.
185. Velsor LW, van Heeckeren A, and Day BJ. Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice. Am J Physiol Lung Cell Mol Physiol 281: L31-L38, 2001.
186. Venkatakrishnan A, Stecenko AA, King G, Blackwell TR, Brigham KL, Christman JW, and Blackwell TS. Exaggerated activation of nuclear factor-κB and altered IκB-β processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 23: 396-403, 2000.
187. Verkman AS, Song Y, and Thiagarajah JR. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. Am J Physiol Cell Physiol 284: C2-C15, 2003.
188. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
189. Wang S, Yue H, Derin RB, Guggino WB, and Li M. Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity. Cell 103: 169-179, 2000.
190. - channel function. Am J Physiol Lung Cell Mol Physiol 281: L71-L78, 2001.
191. Welsh MJ and Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73: 1251-1254, 1993.
192. Willumsen NJ and Boucher RC. Shunt resistance and ion permeabilities in normal and cystic fibrosis airway epithelia. Am J Physiol Cell Physiol 256: C1054-C1063, 1989.
193. Willumsen NJ, Davis CW, and Boucher RC. Intracellular Cl- activity and cellular Cl- pathways in cultured human airway epithelium. Am J Physiol Cell Physiol 256: C1033-C1044, 1989.
194. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, and Doring G. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109: 317-325, 2002.
195. Wu M, Grabe M, Adams S, Tsien RY, Moore HPH, and Machen TE. Mechanisms of pH regulation in the regulated secretory pathway. J Biol Chem 276: 33027-33035, 2001.
196. Wu Q, Lu Z, Verghese MW, and Randell SH. Airway epithelial cell tolerance to Pseudomonas aeruginosa. Respir Res 6: 26, 2005.
197. Xu Y, Clark JC, Aronow BJ, Dey CR, Liu C, Wooldridge JL, and Whitsett JA. Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency. J Biol Chem 278: 7674 -7682, 2003.
198. Xu Y, Liu C, Clark JC, and Whitsett JA. Functional genomic responses to CFTR and CFTRΔ508 in the lung. J Biol Chem. In Press.
199. Zhang Z, Louboutin JP, Weiner DJ, Goldberg JB, and Wilson JM. Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5. Infect Immun 73: 7151-7160, 2005.